##gff-version 3
##sequence-region O00221 1 500
O00221	UniProtKB	Chain	1	500	.	.	.	ID=PRO_0000067007;Note=NF-kappa-B inhibitor epsilon	
O00221	UniProtKB	Repeat	258	291	.	.	.	Note=ANK 1	
O00221	UniProtKB	Repeat	293	322	.	.	.	Note=ANK 2	
O00221	UniProtKB	Repeat	326	355	.	.	.	Note=ANK 3	
O00221	UniProtKB	Repeat	369	398	.	.	.	Note=ANK 4	
O00221	UniProtKB	Repeat	403	432	.	.	.	Note=ANK 5	
O00221	UniProtKB	Repeat	436	465	.	.	.	Note=ANK 6	
O00221	UniProtKB	Modified residue	157	157	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
O00221	UniProtKB	Modified residue	161	161	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000305;evidence=ECO:0000305	
O00221	UniProtKB	Modified residue	183	183	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
O00221	UniProtKB	Natural variant	95	95	.	.	.	ID=VAR_046631;Note=H->Q;Dbxref=dbSNP:rs28362857	
O00221	UniProtKB	Natural variant	194	194	.	.	.	ID=VAR_046632;Note=V->A;Dbxref=dbSNP:rs2233434	
O00221	UniProtKB	Mutagenesis	145	145	.	.	.	Note=No effect. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9135156;Dbxref=PMID:9135156	
O00221	UniProtKB	Mutagenesis	157	157	.	.	.	Note=No degradation. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9135156;Dbxref=PMID:9135156	
O00221	UniProtKB	Mutagenesis	161	161	.	.	.	Note=No degradation. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9135156;Dbxref=PMID:9135156	
O00221	UniProtKB	Sequence conflict	63	64	.	.	.	Note=PA->RP;Ontology_term=ECO:0000305;evidence=ECO:0000305	
O00221	UniProtKB	Sequence conflict	101	101	.	.	.	Note=P->R;Ontology_term=ECO:0000305;evidence=ECO:0000305	
O00221	UniProtKB	Sequence conflict	233	233	.	.	.	Note=A->P;Ontology_term=ECO:0000305;evidence=ECO:0000305	
O00221	UniProtKB	Sequence conflict	402	402	.	.	.	Note=T->S;Ontology_term=ECO:0000305;evidence=ECO:0000305	
